CDC 'strongly' backs Gilead's HIV PrEP Yeztugo, but advocacy groups say access barriers remain

19th September 2025 Uncategorised 0

The CDC’s recommendation for Gilead’s twice-yearly Yeztugo as an HIV PrEP option was hailed by HIV advocacy groups but stirred up pressure for CVS Health to include the drug on its formularies.

More: CDC 'strongly' backs Gilead's HIV PrEP Yeztugo, but advocacy groups say access barriers remain
Source: fierce